title: [Esomeprazole-induced subacute cutaneous lupus erythematosus].
authors.forename: J
authors.initials: J
authors.lastname: Alcántara-González
authors.forename: M T
authors.initials: MT
authors.lastname: Truchuelo-Díez
authors.forename: C
authors.initials: C
authors.lastname: González-García
authors.forename: P
authors.initials: P
authors.lastname: Jaén Olasolo
mesh_terms: D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000974:Antibodies, Antinuclear / Q000097:blood; D001706:Biopsy; D015897:Comorbidity; D064098:Esomeprazole / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008178:Lupus Erythematosus, Cutaneous / Q000097:blood / Q000139:chemically induced* / Q000188:drug therapy / Q000276:immunology; D000068656:Mometasone Furoate; D019338:Polypharmacy; D011244:Pregnadienediols / Q000627:therapeutic use; D011537:Pruritus / Q000139:chemically induced; D012074:Remission Induction; D013831:Thiamine / Q000008:administration & dosage; D014805:Vitamin B 12 / Q000008:administration & dosage; D025101:Vitamin B 6 / Q000008:administration & dosage
chemical_list: D000893:Anti-Inflammatory Agents; D000897:Anti-Ulcer Agents; D000974:Antibodies, Antinuclear; D011244:Pregnadienediols; C035356:SS-A antibodies; C035357:SS-B antibodies; D000068656:Mometasone Furoate; D025101:Vitamin B 6; D064098:Esomeprazole; D014805:Vitamin B 12; D013831:Thiamine